AstraZeneca's £4.4m package for former boss

Tuesday 17 July 2012 05:23 EDT
Comments

Your support helps us to tell the story

From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or producing our latest documentary, 'The A Word', which shines a light on the American women fighting for reproductive rights, we know how important it is to parse out the facts from the messaging.

At such a critical moment in US history, we need reporters on the ground. Your donation allows us to keep sending journalists to speak to both sides of the story.

The Independent is trusted by Americans across the entire political spectrum. And unlike many other quality news outlets, we choose not to lock Americans out of our reporting and analysis with paywalls. We believe quality journalism should be available to everyone, paid for by those who can afford it.

Your support makes all the difference.

AstraZeneca paid its departing chief executive David Brennan up to £4.4m, on top of his pension pot totalling £14m, it emerged yesterday.

However, Mr Brennan, pictured, who quit after growing pressure from shareholders, waived his bonus for the first five months of 2012 following his sudden departure after poor sales and setbacks with AstraZeneca's pipeline of new drugs.

The company released figures in its annual report showing that Mr Brennan was paid a lump sum of £914,122 as part of his notice period, plus a share award of £1.5m for 2010 and potentially another £2m depending on the performance of previous share awards.

The report said his £14m pension pot, which was accrued over his 36 years at the company, would pay him about £970,000 a year.

Mr Brennan has said that the decision to leave the company in April had been made "totally" by himself. However, shareholders had pushed for his departure in what was a key moment of the so-called "shareholder spring".

Join our commenting forum

Join thought-provoking conversations, follow other Independent readers and see their replies

Comments

Thank you for registering

Please refresh the page or navigate to another page on the site to be automatically logged inPlease refresh your browser to be logged in